CEL-SCI Corp (NYSE: CVM) announced that in the month of August it has enrolled 19 patients in its ongoing Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE